At the time of writing, Johnson & Johnson [JNJ] stock is trading at $171.04, up 2.22%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The JNJ shares have gain 2.90% over the last week, with a monthly amount glided 9.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on July 23, 2025, when Erste Group upgraded its rating to a Buy. Previously, Leerink Partners downgraded its rating to Market Perform on May 13, 2025, and kept the price target unchanged to $153. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $190 on November 15, 2024. Daiwa Securities downgraded its rating to a Neutral and reduced its price target to $150 on July 23, 2024. In a note dated April 18, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $170.
For the past year, the stock price of Johnson & Johnson fluctuated between $140.68 and $169.99. Currently, Wall Street analysts expect the stock to reach $162 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $171.04 at the most recent close of the market. An investor can expect a potential drop of -5.29% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
According to Johnson & Johnson [NYSE:JNJ], the company’s sales were 90.62B for trailing twelve months, which represents an 5.76% jump. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.3%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.3 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Johnson & Johnson [NYSE:JNJ] has a current ratio of 1.01. As well, the Quick Ratio is 0.76, while the Cash Ratio is 0.34. Considering the valuation of this stock, the price to sales ratio is 4.55, the price to book ratio is 5.25 and price to earnings (TTM) ratio is 18.29.
Transactions by insiders
Recent insider trading involved REED JOHN C, EVP, Innovative Medicine, R&D, that happened on Jul 17 ’25 when 19137.0 shares were sold. Officer, REED JOHN C completed a deal on Jul 17 ’25 to buy 19137.0 shares. Meanwhile, VP Corporate Controller Decker Robert J sold 6999.0 shares on Feb 25 ’25.
